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11% of screening 
tests, in people with 
no symptoms, found a 
hard-to-treat germ  
that spreads easily.
The Containment 
Strategy keeps new 
threats from spreading. 
Launch at the first sign 
of unusual resistance. 
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Containing Unusual Resistance
Early, aggressive action can prevent spread 
More than 23,000 Americans die each year from infections caused by 
germs resistant to antibiotics. While antibiotic resistance (AR) threats vary 
nationwide, AR has been found in every state. And unusual resistance 
germs, which are resistant to all or most antibiotics tested and are 
uncommon or carry special resistance genes, are constantly developing 
and spreading. Lab tests uncovered unusual resistance more than 
200 times in 2017 in “nightmare bacteria” alone. With new resources 
nationwide, early and aggressive action—when even a single case is 
found—can keep germs with unusual resistance from spreading in health 
care facilities and causing hard-to-treat or even untreatable infections. For 
example, CDC estimates show that this aggressive approach could prevent 
1,600 cases of CRE* in one state over three years. Health departments can 
lead the Containment Strategy and act swiftly with health care facilities and 
CDC at the first sign of unusual resistance.    
State and local health departments can:
• Make sure all health care facilities know what state and local lab
support is available and what isolates (pure samples of a germ) to
send for testing. Develop a plan to respond rapidly to unusual genes
and germs when they first occur.
• Assess the quality and consistency of infection control in health care
facilities across the state. Help improve practices.
• Coordinate with affected health care facilities, the new AR Lab
Network regional labs, and CDC for every case of unusual resistance.
Investigations should include onsite infection control assessments and
colonization screenings for people who might have been exposed.
They could spread it to others. Continue until spread is controlled.
• Provide timely lab results and recommendations to affected health
care facilities and providers. If the patient came from or was
transferred to another facility, alert that facility.
*CRE is carbapenem-resistant
Enterobacteriaceae.
Germs constantly develop resistance against new and older antibiotics. 
Antibiotic-resistant germs can cause difficult-to-treat or untreatable 
infections. Some types of antibiotic resistance are already widespread. 
PREVENTING AN UNUSUAL ANTIBIOTIC RESISTANCE WILDFIRE
CDC’S AR LAB NETWORK UNCOVERS ANTIBIOTIC RESISTANCE & SILENT SPREAD
UNUSUAL ANTIBIOTIC-RESISTANT GERMS
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PROBLEM:
Antibiotic-resistant germs can 
spread like wildfire.
SOURCE: CDC Vital Signs, April 2018.2
• Health department identified an unusual resistance germ in a
patient who recently received health care outside the US.
• Health department and the facility in Tennessee did infection
control assessments and colonization screenings within 48 
hours. No spread found. 
• Moving forward, CDC’s AR Lab Network regional labs expanded
services to test patients in the US with recent health care 
outside the country.
• Health department identified an unusual resistance germ in a
nursing home patient.
• Health department and the facility did infection control assessments 
and screened 30 patients for colonization. Investigation revealed the
germ may have spread to 5 additional people. 
• Facility used infection control and contact precautions, such as
gloves and gowns, to help stop spread. 
• No further spread found during follow-up assessments.
Resistant to all or most antibiotics tested, making them hard 
to treat, and 
Uncommon in a geographic area or the US, or
Have special genes that allow them to spread their resistance 
to other germs
Examples of unusual resistance: Vancomycin-resistant Staphylococcus aureus 
(VRSA), Candida auris, and certain types of “nightmare bacteria” such as 
carbapenem-resistant Enterobacteriaceae (CRE).
Once antibiotic resistance spreads,  
it is harder to control—like a wildfire.
Finding and responding to unusual 
resistance early, before it becomes 
common, can help stop its spread  
and protect people.
New or rare types of antibiotic 
resistance can be easier to contain when 
found rapidly—like a spark or campfire. 
1 IN 4 GERMS TESTED WAS POSITIVE. 
25% of the germs had special genes that 
allow them to spread their resistance to other 
germs. In response, many investigations were 
conducted and screening tests were performed. 
1 IN 10 SCREENING TESTS WAS POSITIVE. 
If left undetected, patients without  
symptoms could continue spreading 
rare, hard-to-treat germs in the  
health care facility.
From people with and 
without symptoms  
of infection
Between facilities
Between germs
ANTIBIOTIC RESISTANCE CAN SPREAD
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Public health teams 
nationwide can launch early, 
aggressive responses to contain 
spread and protect people—
at the first sign of antibiotic 
resistance, every time. 
PREVENTING AN UNUSUAL ANTIBIOTIC RESISTANCE WILDFIRE
Containment Strategy: Be on guard to contain the first spark.
THE NATION CAN IDENTIFY AND RESPOND TO UNUSUAL ANTIBIOTIC RESISTANCE 
SOURCE: AR Investment Map: www.cdc.gov/ARinvestments. 
Health care facilities, health  
departments, and CDC are  
ON ALERT for antibiotic resistance.
 
 
 
In addition to leading the Containment Strategy, CDC is 
working with other Federal agencies to combat antibiotic 
resistance nationwide by preventing infections and improving 
antibiotic use. CDC’s activities are supported by ongoing 
resources from Congress.
Find guidance, lab protocols, and more resources: 
www.cdc.gov/HAI/Outbreaks/MDRO
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THE CONTAINMENT STRATEGY
THE FEDERAL GOVERNMENT IS:
• Monitoring resistance and sounding the alarm when 
threats emerge. CDC develops and provides new 
lab tests so health departments can quickly identify  
new threats. 
• Improving identification through CDC’s new  
AR Lab Network in all 50 states, 5 large cities, and 
Puerto Rico, including 7 regional labs and a national 
tuberculosis lab for specialty testing.
• Supporting prevention experts and programs 
in every state, and providing data and 
recommendations for local prevention and 
response.
• Testing innovative infection control and prevention 
strategies with health care and academic partners.   
STATE AND LOCAL HEALTH DEPARTMENTS AND 
LABS CAN:
• Make sure all health care facilities know what state 
and local lab support is available and what isolates 
(pure samples of a germ) to send for testing. 
Develop a plan to respond rapidly to unusual genes 
and germs when they first appear.
• Assess the quality and consistency of infection 
control in health care facilities across the state, 
especially in facilities with high-risk patients and 
long stays. Help improve practices.
• Coordinate with affected health care facilities, the 
new AR Lab Network regional lab, and CDC for 
every case of unusual resistance. Investigations 
should include onsite infection control assessments 
to find spread. Consider colonization screenings. 
Continue until spread is controlled. 
• Provide timely lab results and recommendations to 
affected health care facilities and providers. If the 
patient came from or was transferred to another 
facility, alert that facility.   
• Find resources: www.cdc.gov/hai/outbreaks/mdro
HEALTH CARE FACILITIES CAN:
• Plan for unusual resistance arriving in your facility. 
Find resources: www.cdc.gov/hai/outbreaks/mdro
• Leadership: Work with the health department to stop 
spread of unusual resistance. Review and support 
infection control in the facility.
• Clinical labs: Know what isolates to send for testing. 
Establish protocols that immediately notify the health 
department, healthcare provider, and infection control 
staff of unusual resistance. Validate new tests to 
identify the latest threats. If needed, use isolates from 
www.cdc.gov/ARIsolateBank.
• Healthcare providers, epidemiologists, and infection 
control staff: Place patients with unusual resistance 
on contact precautions, assess and enhance infection 
control, and work with the health department to 
screen others. Communicate about status when 
patients are transferred. Continue infection control 
assessments and colonization screenings until spread 
is controlled. Ask about any recent travel or health 
care to identify at-risk patients. 
EVERYONE CAN:
• Inform your healthcare provider if you recently 
received health care in another country or facility. 
• Talk to your healthcare provider about preventing 
infections, taking good care of chronic conditions and 
getting recommended vaccines. 
• Practice good hygiene, such as keeping hands clean 
with handwashing or alcohol-based hand rubs, and 
keep cuts clean until healed. 
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WHAT CAN BE DONE
